Trial Profile
An open-label, single-arm, multicenter phase II trial to evaluate panitumumab in KRAS wild-type locally advanced rectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 02 Dec 2015 New trial record